ArticleProceedings of the National Academy of Sciences of the United States of America2025

Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.

Naruhisa Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.